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Mitogen-activating protein kinases (MAPKs) constitute a family of serine/threonine 
kinases which play critical roles in transducing a variety of signals. Deregulated MAPKs 
are associated with chronic inflammatory diseases and cancer. It is difficult to attribute 
any output to a given MAPK because several MAPKs and other pathways are co-
activated at the same time. Activation of a given MAPK individually would disclose the 
function of this MAPK. This could be achieved by expression of intrinsically active 
variants of MAPKs.  
The goal of this Master’s thesis was to try and develop such novel variants of the yeast 
MAPK Hog1 and the human MAPK p38γ and to study their mechanism of action. 
Previous studies showed that particular mutations in a structural element termed the 
“hydrophobic core” rendered the yeast Hog1/p38 intrinsically active. I introduced many 
more mutations to this core. Amazingly, each mutation rendered Hog1 intrinsically active 
suggesting that the core is an inherent structural locker of spontaneous activity. I then 
introduced 20 point mutations to p38γ and characterized them in vitro and in cell culture. 
None of the mutations seemed to render the kinase intrinsically active, once again 
verifying the fact that despite significant sequence and structural similarity, p38 isoforms 
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1.1 Signal Transduction Pathways are Essential to a Cell’s Fate  
In order to survive and properly function under the constant changes in their 
extracellular and intracellular environments, living cells must be able to sense the 
changes, compile the information and respond accordingly. Examples of extracellular 
signals that evoke these cellular activities include physical elements (e.g. radiation, 
pressure, heat), chemicals (e.g. reactive oxygen species (ROS), pH, cytokines, growth 
factors) as well as living organisms (e.g. pathogens, neighbouring cells). In addition, an 
assorted number of intracellular events such as DNA damage or aggregates of denatured 
proteins ignite dramatic cellular responses. Notably, not only there exist a large number 
of signals, many of them may co-exist at a given time. A complex and integrative 
network of biochemical reactions deals with these complex situations. 
The activity of an enzyme which functions within this web of reactions is commonly 
regulated in many ways and may function in cooperation with other proteins. In most 
cases, it is very difficult to identify the definite functions of any given molecule within 
the web and to study its relative contribution to the biological and at times, the 
pathological outcome. A useful and a clear-cut approach for revealing the specific 
functions of a given enzyme is to activate it individually in vivo without activating the 
other components in the web and to follow the consequences. Only under such condition 
will it be possible to attribute a biochemical, physiological or pathological output to the 




1.2 The Mitogen-activating Protein Kinase (MAPK) Cascades are 
Central Signal Transduction Pathways that are Regulated via a 
Series of Phosphorylations 
The cellular response to many extracellular and intracellular stresses often involves 
the Mitogen-Activating Protein Kinase (MAPK) signal transduction pathway. These 
cascades are evolutionary conserved from yeast to human (Kyriakis & Avruch, 2012). 
The core MAPK cascade is composed of three components known as a MAPK Kinase 
Kinase (MAPKKK), a MAPK Kinase (MAPKK) and a MAPK as summarized in Figure 
1 (J. English et al., 1999). The pathway is essentially linear but once a MAPK is activated 
by its MAPKK, it phosphorylates a large number of substrates (Lewis, Shapiro, & Ahn, 
1998). 
The mammalian genome has at least 11 different genes that encode MAPKs. These 
genes are sub-classified into 4 distinct groups, based on sequence homology and also 
other criteria discussed later. The 4 groups are extracellular signal-regulated kinases 
(ERKs), c-Jun amino-terminal kinases (JNKs), Big MAP Kinases (ERK5/BMKs) and the 
p38 proteins. Each of these families, is composed of several isoforms and splicing 
variants. In most cases, there are no known specific functions for a given isoform or a 
splicing variant (Aebersold et al., 2004; Gupta et al., 1996).  
The 4 subfamilies of MAPKs respond differently to extracellular signals and have 
distinct substrate specificity. ERKs are primarily activated by growth factors and are 
associated with cell proliferation, cell death and differentiation depending on the cell-type 
and the stimuli (Lin et al., 1998; J. Zhu, Woods, McMahon, & Bishop, 1998). p38s and 
JNKs (also classified as Stress-Activated Protein Kinase (SAPKs)) are primarily involved 
in stress response, apoptosis, cell-cycle regulation and cell differentiation (Eilers, 
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Whitfield, Babij, Rubin, & Ham, 1998; Ono & Han, 2000; Wagner & Nebreda, 2009; 
Xia, Dickens, Raingeaud, Davis, & Greenberg, 1995; Zhang & Shapiro, 2000).  Notably, 
although MAPKs respond differently to signals, in most cases, they are all concomitantly 
activated, each family to a different degree.  
Although different isoforms from the same subfamily are redundant from many 
aspects and phosphorylate the same substrates, there are indications that each isoform has 
specific functions too. For example, p38α is essential for embryonic development 
whereas p38β, p38δ and p38γ are not (Beardmore et al., 2005; Hui et al., 2007; Sabio et 
al., 2005). The situation is somewhat different in the JNK subfamily as mice which lack 
either JNK1 or JNK2 are viable and fertile but mice which lack both JNK1 and JNK2 are 
embryonic lethal suggesting that JNK1 and JNK2 are redundant for embryonic 
development (Kuan et al., 1999).  
Each MAPK family is activated by specific MAPKKs. This study focuses on the p38 
kinases that are phosphorylated mainly by the MAPKKs MKK3 and MKK6. This study 
also studied the yeast ortholog of p38 kinases, called Hog1 which is activated by a 





















Figure 1. A schematic diagram showing the major components of the mammalian 
MAPK pathways.  Activation by phosphorylation is shown by the arrows. The left 







1.3 Activation of MAPKs Require Unique Dual Phosphorylation 
The MAPK cascades (summarized in Figure 1.) are not spontaneously active. In fact, 
when cells are not exposed to a relevant signal, the catalytic activity of MAPKs in a cell 
is kept very low. Upon stimulation, the relevant MAPK pathway is induced resulting in 
strong activation of its target MAPK. The activation of MAPKs requires a unique dual 
phosphorylation catalyzed by MAPKKs, at a threonine (Thr) and a tyrosine (Tyr) residue 
which are part of a TXY motif at its activation loop (Han, Lee, Bibbs, & Ulevitch, 1994; 
Kyriakis & Avruch, 2012; Zarubin & Han, 2005). Phosphorylation of both the Thr and 
Tyr phosphoacceptors is essential for the activation of MAPK, a phenomenon that is 
unique to MAPKs. Yet, some studies reported that mono-phosphorylated (on Thr only) 
still manifest a significant catalytic and even biological activity. (Bell & Engelberg, 2003; 
Robbins et al., 1993; Zhou & Zhang, 2002).  
1.4 Role of MAPKs in Human Diseases 
Abnormal activity levels of MAPKs have been found in numerous human diseases. 
For example, a high activity of JNKs have been reported in neurodegenerative diseases 
such as Parkinson’s disease, in acute myeloid leukemia and also in malignant melanoma 
(Govindarajan et al., 2003; Kuan & Burke, 2005; Saporito, Hudkins, & Maroney, 2002; 
X. Zhu, Lee, Raina, Perry, & Smith, 2002). Elevated p38 activity is measured in all 
chronic inflammatory diseases including rheumatoid arthritis and inflammatory bowel 
diseases (IBD) including Crohn’s diseases. p38α is also overactive in breast cancer and 
congestive heart failure (J. M. English & Cobb, 2002; Esteva et al., 2004; Kumar, 
Boehm, & Lee, 2003; Waetzig, Seegert, Rosenstiel, Nikolaus, & Schreiber, 2002). 
Unregulated activity of Erk is measured in essentially all types of cancer (Donovan, 
Milic, & Slingerland, 2001; Gioeli, Mandell, Petroni, Frierson, & Weber, 1999; 
Govindarajan et al., 2003; Mansour et al., 1994; Price et al., 1999).  
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It is not known whether the high activity levels of the MAPKs detected in patients is 
the primary cause of the disease or if this high activity is a mere indirect consequence of 
the disease. To address these questions, it would be beneficial to activate a given MAPK 
molecule individually in cells or animals and search for pathological phenotypes. Thus, 
the ability to somehow activate individually a single enzyme within the web of reactions 
is essential for revealing the specific biochemical and biological functions of that 
enzyme, as explained above, and also for exploring its pathological effects if any. 
1.5 The p38 Subfamily 
The p38 MAPK subfamily consists of 4 members, p38α, p38β, p38δ and p38γ. This 
subfamily can then be further divided into 2 distinct groups of p38α and p38β that share 
high sequence similarity (75% identical) and downstream substrates and also share 
biochemical and pharmacological properties while the other group consist of p38γ and 
p38δ which are 70% identical to each other (Cuenda & Rousseau, 2007). The tissue 
expression pattern for each isoform varies. p38α has been found to be expressed at 
significant levels in most cells types whereas the other isoforms are found to be expressed 
in a more tissue-specific pattern (Cuadrado & Nebreda, 2010). For example, p38β has 
been found to be expressed mainly in the brain, p38δ is found mainly in the testis, 
pancreas, kidney and intestine (Goedert, Cuenda, Craxton, Jakes, & Cohen, 1997) while 






1.6 p38γ, a Somewhat Neglected Isoform 
A large part of this Master’s thesis is focused on the p38γ isoform. The human p38γ 
is a serine/threonine, proline-directed protein kinases of 367 amino acids and has a 
predicted molecular weight of 42kDa. p38γ is unique among the p38 family in its ability 
to bind to PDZ domains (Hasegawa et al., 1999; Sabio et al., 2005; Sabio et al., 2004).  
p38γ may be involved in regeneration of tissues, cancer and metabolic diseases. 
Levels of p38γ has been found elevated in many human diseases, especially in cancer. 
For example, an elevated level of p38γ has been reported during Ras-induced 
transformation in both rat intestinal epithelial cells (IECs) and invasive breast cancer. Ras 
has been identified to be a positive regulator of p38γ expression and in turn, p38γ 
mediates the Ras non-mitogenic signaling to promote invasion (Qi et al., 2006). This is 
also seen when p38γ was knocked down in IECs and this resulted in the blocking of Ras 
transformation activity and significantly attenuated the oncogenic characteristic of breast 
cancer. What is surprising is that Ras only increased the transcript and protein levels and 
not the phosphorylation status of p38γ, and that the depletion of p38γ inhibited Ras 
transformation. Significantly, this elevated level of p38γ was also observed in primary 
human colon cancer cells (Tang, Qi, Mercola, Han, & Chen, 2005).  
p38γ has also been implicated in human rhabdomyosarcoma cells. MyoD, a 
downstream substrate target for p38γ, inhibits cell proliferation and promotes muscle 
differentiation. Rhabdomyosarcoma, a tumour caused by an accumulation of muscle 
precursors, occurs when there is a block in the differentiation program and the 
deregulated proliferation even though MyoD is expressed properly. This has been found 
to be due to a deficiency in p38 MAPK activation. The enforced activation of p38γ 
signaling by a constitutively active MKK6 mutant (MKK6EE) arrested cell proliferation 
and allowed terminal differentiation (Puri et al., 2000). It was later found that p38γ 
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directly phosphorylates MyoD on Serine199 and Serine 200 to enhance the occupancy 
onto the promoter of myogenin and therefore positively regulate the expansion of 
transient amplifying myogenic precursor cells during muscle growth and regeneration 
and preventing rhabdomyosarcoma (Gillespie et al., 2009). However, it is important to 
note that even though MKK6EE is able to reverse the effects of rhabdomyosarcoma, that 
MKK6EE is also able to activate the other p38 isoforms as well and therefore, not a 
suitable therapeutic strategy. 
One important point to note is that there have not been any reports of mutated p38γ in 
patients suffering from elevated p38γ levels, both in activity levels or protein expression 





1.7 The Hog1 Cascade of the yeast Saccharomyces cerevisiae is a 
MAPK Pathway Activated in Response to High Osmolarity  
Another focus of this Master’s thesis is Hog1, the yeast ortholog of mammalian p38. 
The Baker’s yeast, Saccharomyces cerevisiae (S. cerevisiae), possesses 5 different 
MAPKs which function in 5 different cascades with differing stimulus for activation 
(summarized in Figure 2). These cascades are highly conserved throughout evolution 
both structurally and functionally.  Hog1 is activated primarily by osmotic pressure but 
also by stresses such as high ROS concentration, acid, cesium chloride, cell wall damage 
and heat stress (Hohmann, 2002; Saito & Posas, 2012). The MAPKK of Hog1 is Pbs2 
which is in turn phosphorylated by the MAPKKKs, Ste11 and Ssk2/22. Hog1 and Pbs2 
are essential for cell proliferation under osmostress such that cells lacking either gene do 
not grow in the presence of high concentrations of osmolytes (Brewster, de Valoir, 










Figure 2. Overview of the 5 MAPKs cascade in yeast. 
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1.8 Past Attempts to Develop Intrinsically Active Variants of 
MAPKs 
As explained above, an elegant way to study the precise functions of an enzyme 
within a complex biochemical network would be the activation of that enzyme 
individually while other components of the net are dormant. Once activated alone within 
the network, any output, by definition, is a result of the activity of that enzyme per se. 
Activation of a given enzyme individually could be achieved by expressing, in the 
relevant biological system, intrinsically active variants (regulation-independent) of that 
enzyme. Since MAPKs are tightly regulated, it is rather difficult to design their 
intrinsically active variants. 
The absolute dependence of MAPKs’ activity on MAPKK-dependent dual 
phosphorylation makes the development of an intrinsically active variant of MAPKs 
particularly difficult. In many enzymes that are regulated by phosphorylation, the 
phosphorylated residue could be mimicked by replacing it (serine or threonine) with 
aspartic acid (Asp) or glutamic acid (Glu) (Cowley, Paterson, Kemp, & Marshall, 1994; 
Mansour et al., 1994). This approach is not possible for MAPKs. For example, when the 
Thr phosphoacceptor in Erk1/2 was replaced with Glu, it resulted in 10 fold decrease in 
catalytic activity (Robbins et al., 1993). Interestingly, when the Thr  phosphoacceptor in 
the yeast homolog of p38, Hog1, was replaced with Glu, it abolished the kinase capability 
of Hog1 (Bell & Engelberg, 2003). In addition there is no amino acid available which 
could be used to accurately mimic a phosphorylated Tyr residue. Therefore, to develop 
intrinsically active variants of MAPKs, a simple mutagenesis of the activation loop 
phosphoacceptors residues is not the solution.  
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Another approach to increase the activity of a given enzyme per se is to overexpress 
it. This approach is useful for enzymes that exhibit some degree of spontaneous, basal 
catalytic activity. In MAPKs, the tight regulation ensures extremely low activity, in many 
cases undetected basal activity, making the overexpression approach not useful. Finally, 
there is no particular extracellular signal that would activate in a highly specific manner a 
given MAPK family, let alone a given isoform or a splicing variant. 
As common approaches are not valid for MAPKs, some specific approaches were 
considered. One attempt to develop intrinsically active variants of MAPKs was to form a 
MAPKK-MAPK chimeric protein. This approach is essentially useful and a chimeric 
MEK1-ERK2 protein was found to be catalytically and biologically active and found to 
be able to phosphorylate its downstream targets, Elk1 and AP-1 (Robinson, Stippec, 
Goldsmith, White, & Cobb, 1998). Both Elk1 and AP-1 are transcription factors and were 
found to elicit the neurite differentiation of PC12 cells. Furthermore, this strategy was 
also successful when it applied to fuse a chimeric protein of MKK7-JNK1 which 
functioned as an intrinsically active variant of JNK (Zheng, Xiang, Hunter, & Lin, 1999). 
This strategy, even though successful, has a flaw. In living cells, MAPKKs and MAPKs 
are regulated differently and are localized in different subcellular destinations by their 
respective regulators. By fusing both the MAPKK and MAPK together, the fusion protein 
loses proper regulation and this resulted in abnormal activity observed within the cell 
(Askari et al., 2006). 
Another strategy was to apply genetic screens for gain-of-function mutations. A 
screen in Drosophila melanogaster (D. melanogaster) for mutants that allowed 
development of the eye in the absence of proper signaling discovered a mutation in the D. 
melanogaster Erk, called rolled (Brunner et al., 1994). However, biochemical studies 
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revealed that the mutated rolled is not spontaneously active but less sensitive to 
phosphatases (Bott, Thorneycroft, & Marshall, 1994; Cornelius & Engel, 1995). 
Genetic screens that finally provided bona fide intrinsically active variants were 
performed on the S. cerevisiae MAPK cascades.  One screen took advantage of the Hog1 
pathway. As described above, yeast cells lacking the MAPKK Pbs2 cannot proliferate 
under osmotic stress because the MAPK Hog1 cannot be activated (see Figure 5, upper 
row in each panel). The rationale of the screen was that these Δhog1Δpbs2 cells could 
perhaps still grow under the restrictive conditions if they express an intrinsically active, 
Pbs2-independent Hog1which fulfills its catalytic and biological duties in the total 
absence of its activator Pbs2 (see scheme in Figure 4). Indeed, such mutated, intrinsically 
active Pbs2-independent Hog1 variants were identified in the screen. These mutations, 
the first to render a MAPK independent of its MAPKK were Hog1Y68H, Hog1D170A, 
HogF318S, Hog1F318L, Hog1W320R, Hog1F322L and Hog1W332R (Bell, Capone, Pashtan, 
Levitzki, & Engelberg, 2001). As some of the mutations occur in residues that are 
conserved in mammalian p38, equivalent mutations were inserted to the mammalian 
MAPKs. However, only a few mutations were relevant to p38s. Only p38αD176A, 
p38αY323S, p38αY323, p38αF327L and p38αF327S resulted in intrinsically active variants of 
p38α but p38αY68H and p38αW337R did not. For p38β, only p38βD176A, p38βV327S and 
p38βY323L were intrinsically active while for p38γ only p38γD179A was intrinsically active. 
In the case of p38δ, only the combination of point mutations of p38δD176A+F324S resulted in 
an intrinsically active variant (Avitzour et al., 2007; Diskin, Askari, Capone, Engelberg, 




None of the mutations identified from the Hog1 screen were relevant to Erk (see 
Table 3 in Levin-Salomon et al., 2008). Active variants of Erk2 were obtained eventually 
through a similar screen in yeast using Mpk1 (instead of Hog1) and the mutations 
obtained were indeed totally different (occurring in different domains) from those which 
rendered Hog1 and p38 intrinsically active (Levin-Salomon, Kogan, Ahn, Livnah, & 
Engelberg, 2008). An attempt at screening for intrinsically active variants for JNK using 
similar yeast system or by introducing point mutations that rendered Hog1, p38α or Erk2 
intrinsically active into JNKs did not yield any active variant of JNK (our unpublished 
results). 
The success in discovering mutations that rendered Hog1 intrinsically active and the 
fact that they are partially relevant to p38 but yet not relevant at all for ERKs and JNKs 
raises interesting questions. For example, what is the mechanism of their activity and 
why this mechanism is not relevant to all MAPK families? Another question is whether 
we can apply the knowledge obtained from mutations that rendered Hog1/p38 and Erk 
intrinsically active in a way not applied so far - namely, perhaps using the same site but 
not the same mutations. The question is important for some isoforms. For example, for 
p38γ, there are currently no efficient intrinsically active mutants. Efforts to introduce the 
same point mutations that rendered constitutive activity in other p38 isoforms were only 
partially successful. The mutations F330S (F327S in p38α) did not confer intrinsic 
activity to p38γ while D179A (D176A in p38α) only increased basal activity marginally, 
about only 6.5% relative to dually phosphorylated wild type p38γ (Avitzour et al., 2007). 
Many of the mutations that conferred intrinsic activity to p38α, Erk1/2 and Hog1 have 
not been introduced into p38γ yet. This study will look at both the mechanistic aspect of 
the active mutants and at the possibility of producing more active variants for p38γ.  
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1.9 Several of the mutations that rendered Hog1 Intrinsically Active 
Occurred in Hydrophobic Residues that Interact to Form a 
“Hydrophobic core”. Are these Interactions Locking Hog1’s 
Spontaneous Activity? 
 Many of the point mutations which rendered Hog1 intrinsically active occurred in 
residues that are conserved in p38α. Analysis of the crystal structure of p38α (crystal 
structure of Hog1 is not determined), revealed that 4 of the residues (Tyr-69, Tyr-323, 
Phe-327 and Trp-337 in p38α) in which point mutations occurred form hydrophobic 
interactions with each other. This array of interactions, termed a “hydrophobic core”, 
stabilizes the interactions between L16 loop and the αC-helix (summarized in Figure 3). 
The participating residues are the L16 helix residues Tyr-323, Phe-327 and Trp-337 and 
the αC-helix residue Tyr-69 (Figure 3) (Diskin, Lebendiker, Engelberg, & Livnah, 2007). 
These residues are equivalent to Tyr-68, Phe-318, Phe-322 and Trp-332 in Hog1. The 
fact that the unbiased screen hit all residues of the hydrophobic core raises the idea that 
the core is kind of a locker of intrinsic activity such that any mutation that modifies it 
would render the kinase intrinsically active. Supporting this notion is the fact that the 
hydrophobic core residues are highly conserved in all isoforms and somewhat less 
conserved in JNKs and ERKs. In p38γ for example, they correspond to the Tyr-72, Tyr-













Figure 3. Crystal structure of the hydrophobic core in p38α. Numbers in the diagram 
indicate the positions in p38α. Equivalent positions in Hog1 and p38γ are indicated in the 
call out ovals. 
However, when Tyr-69, Tyr-323 and Trp-337 of p38α were mutated to histidine, 
serine/leucine and arginine (the mutations which conferred Hog1 intrinsic activity) 
respectively, resulted in very low activity (1% of dually-phosphorylated p38α wild-type) 
or even no activity (Avitzour et al., 2007; Diskin et al., 2004). Point mutations on the 
Phe-327 which reside in the “hydrophobic core” did confer intrinsic activity to p38α. 
This indicated that the hydrophobic core is important for intrinsic activity for p38α but 
perhaps not as important as in Hog1. It may also suggest that the theory that any 
disruption of the original hydrophobic interactions would render Hog1 active is not 
correct. Therefore, in order to better understand the mechanism in the “hydrophobic core” 
and to rigorously test the theory, we shall introduce a large number of mutations to the 
hydrophobic core and monitor how many of them (if any at all) would render it 
intrinsically active. In parallel, we shall continue the effort to introduce point mutations 
into p38γ in order to obtain a useful active variant for this isoform.  
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1.10 Research Goals 
1. To test the hypothesis that the hydrophobic core is a molecular locker of Hog1’s 
activity. Namely testing whether any modification of the core would render Hog1 
intrinsically active. 
We shall introduce a large number of point mutations into all residues of the 
“hydrophobic core” and test whether the resulting mutants can rescue both hog1Δ or 
hog1Δpbs2Δ cells from osmotic pressure. 
2. To develop and characterize  a variety of  mutants of p38γ to produce 
intrinsically active variants of this isoform. 
We shall introduce into p38γ point mutations which conferred intrinsic activity to 
Hog1, p38α or Erk1/2 and systematically check the activity of the resulting mutants. 
Mutants will be tested first as recombinant purified proteins by Western Blot to observe 
whether the point mutations rendered p38γ phosphorylated on its TGY motif, perhaps by 
autophosphorylation. These proteins will also be tested via in vitro kinase assay using 
radioactive [γ-32P] ATP to check its activity on ATF-2. These mutants will also be 
expressed and assayed in mammalian cells in culture (HEK293T cells).  
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2. Materials and Methods 
2.1 Yeast Strains and Media 
Saccharomyces cerevisiae (S. cerevisiae) used in this study were JBY13 (MATa. 
leu2, ura3, his3, trp1, ade2, lys2, hog1::TRP1) (Brewster et al., 1993) and hog1Δpbs2Δ 
(MATa, leu2, ura3, his3, trp1, ade2, lys2, hog1:TRP1, pbs2::LEU2) (Maayan et al., 
2012). Yeast cultures were maintained either on yeast extract peptone dextrose (YPD) 
(1% yeast extract, 2% Peptone, 2% glucose and 0.7M, 0.8M or 1.0M sodium chloride 
(NaCl) where indicated) or on synthetic medium yeast nitrogen base (-URA) (0.17% 
yeast nitrogen base without amino acid and ammonium sulfate, 0.5% (NH4)2SO4, 2% 
glucose, 40mg/liter of adenine, histidine, tryptophan, lysine and leucine each). 
2.2 Site-directed Mutagenesis of Hog1 and Subcloning into 
pAES426 vector 
Site-directed mutagenesis was performed on pBS-HA-Hog1WT as a template with the 
QuikChange II Site-Directed Mutagenesis Kit (Agilent) as per manufacturer’s instruction 
with relevant primers. Primers used are listed in Table 1. The cDNA was then cloned into 
pAES426 using HindIII and NotI. Ligation was performed using T4 DNA Ligase 








Table 1. Primers used in site-directed mutagenesis reactions for Hog1. 
Primer name Primer sequence 
HOG1 F318A Forward 5’- CAGTAGCCGATGCCAAGGCCGATTGGCACTTTAATG -3’ 
HOG1 F318A Reverse 5’- CATTAAAGTGCCAATCGGCCTTGGCATCGGCTACTG -3’ 
HOG1 F318P Forward 5’- CAGTAGCCGATGCCAAGCCCGATTGGCACTTTAATG -3’ 
HOG1 F318P Reverse 5’- CATTAAAGTGCCAATCGGGCTTGGCATCGGCTACTG -3’ 
HOG1 F318Y Forward 5’- CAGTAGCCGATGCCAAGTACGATTGGCACTTTAATG -3’ 
HOG1 F318Y Reverse 5’- CATTAAAGTGCCAATCGTACTTGGCATCGGCTACTG -3’ 
HOG1 F318T Forward 5’- CCAGTAGCCGATGCCAAGACCGATTGGCACTTTAATG -3’ 
HOG1 F318T Reverse 5’- CATTAAAGTGCCAATCGGTCTTGGCATCGGCTACTGG -3’ 
HOG1 F318E Forward 5’- CCAGTAGCCGATGCCAAGGAGGATTGGCACTTTAATGACG -3’ 
HOG1 F318E Reverse 5’- CGTCATTAAAGTGCCAATCCTCCTTGGCATCGGCTACTGG -3’ 
HOG1 F318R Forward 5’- CCAGTAGCCGATGCCAAGAGGGATTGGCACTTTAATGACG-3’ 
HOG1 F318R Reverse 5’-CGTCATTAAAGTGCCAATCCCTCTTGGCATCGGCTACTGG -3’ 
HOG1 F318V Forward 5’- CAGTAGCCGATGCCAAGGTCGATTGGCACTTTAATG -3’ 
HOG1 F318V Reverse 5’- CATTAAAGTGCCAATCGACCTTGGCATCGGCTACTG -3’ 
HOG1 Y68A Forward 5’- GCTGGCCAAAAGGACAGCTCGTGAACTAAAACTAC -3’ 
HOG1 Y68A Reverse 5’- GTAGTTTTAGTTCACGAGCTGTCCTTTTGGCCAGC -3’ 
HOG1 Y68F Forward 5’- GCTGGCCAAAAGGACATTTCGTGAACTAAAACTAC -3’ 
HOG1 Y68F Reverse 5’- GTAGTTTTAGTTCACGAAATGTCCTTTTGGCCAGC -3’ 
HOG1 Y68K Forward 5’- GCTGGCCAAAAGGACAAATCGTGAACTAAAACTAC -3’ 
HOG1 Y68K Reverse 5’- GTAGTTTTAGTTCACGATTTGTCCTTTTGGCCAGC -3’ 
HOG1 Y68P Forward 5’- GCTGGCCAAAAGGACACCTCGTGAACTAAAACTAC -3’ 
HOG1 Y68P Reverse 5’- GTAGTTTTAGTTCACGAGGTGTCCTTTTGGCCAGC -3’ 
HOG1 D170G Forward 5’- GTCTAGCAAGAATTCAAGGCCCTCAAATGACAGGC -3’ 
HOG1 D170G Reverse 5’- GCCTGTCATTTGAGGGCCTTGAATTCTTGCTAGAC -3’ 
HOG1 D170F Forward 5’- GTCTAGCAAGAATTCAATTCCCTCAAATGACAGGC -3’ 
HOG1 D170F Reverse 5’- GCCTGTCATTTGAGGGAATTGAATTCTTGCTAGAC -3’ 
HOG1 D170P Forward 5’- GTCTAGCAAGAATTCAACCCCCTCAAATGACAGGC -3’ 
HOG1 D170P Reverse 5’- GCCTGTCATTTGAGGGGGTTGAATTCTTGCTAGAC -3’ 
HOG1 D170S Forward 5’- GTCTAGCAAGAATTCAAAGCCCTCAAATGACAGGC -3’ 
HOG1 D170S Reverse 5’- GCCTGTCATTTGAGGGCTTTGAATTCTTGCTAGAC -3’ 
HOG1 F322A Forward 5’- CAAGTTCGATTGGCACGCTAATGACGCTGATCTGCC -3’ 
HOG1 F322A Reverse 5’- GGCAGATCAGCGTCATTAGCGTGCCAATCGAACTTG -3’ 
HOG1 F322W Forward 5’- CAAGTTCGATTGGCACTGGAATGACGCTGATCTGCC -3’ 
HOG1 F322W Reverse 5’- GGCAGATCAGCGTCATTCCAGTGCCAATCGAACTTG -3’ 
HOG1 W332A Forward 5’- GATCTGCCTGTCGATACCGCGCGTGTTATGATGTACTC -3’ 
HOG1 W332A Reverse 5’- GAGTACATCATAACACGCGCGGTATCGACAGGCAGATC -3’ 
HOG1 W332F Forward 5’- GATCTGCCTGTCGATACCTTTCGTGTTATGATGTACTC -3’ 
HOG1 W332F Reverse 5’- GAGTACATCATAACACGAAAGGTATCGACAGGCAGATC -3’ 
HOG1 W332L Forward 5’- GATCTGCCTGTCGATACCCTGCGTGTTATGATGTACTC -3’ 
HOG1 W332L Reverse 5’- GAGTACATCATAACACGCAGGGTATCGACAGGCAGATC -3’ 
HOG1 W332S Forward 5’- GATCTGCCTGTCGATACCTCGCGTGTTATGATGTACTC -3’ 
HOG1 W332S Reverse 5’- GAGTACATCATAACACGCGAGGTATCGACAGGCAGATC -3’ 
HOG1 W320F Forward 5’-GATGCCAAGTTCGATTTTCACTTTAATGACGCTG -3’ 
HOG1 W320F Reverse 5’- CAGCGTCATTAAAGTGAAAATCGAACTTGGCATC -3’ 
HOG1 W320A Forward 5’- GATGCCAAGTTCGATGCGCACTTTAATGACGCTG -3’ 




2.3 Preparation of Competent Yeast Cells for Transformation  
 Yeast cells were inoculated into 15ml of YPD and grown overnight at 30°C with 
shaking at 225rpm. The yeast cells were then pelleted by centrifugation at 3500x g for 5 
min and the supernatant was discarded. To make the yeast cells competent, 4ml of 
transformation buffer (0.1M lithium acetate (LiAc), 10mM Tris-Cl, 1mM EDTA, pH 7.5) 
was added to resuspend the pellet and incubated with shaking at 30°C for 45 min. 100µl 
of 1M DTT was added after 45 min of incubation and the cells are then incubated for 
another 15 min at 30°C. After incubation for 1hr, the cells were collected by 
centrifugation at 3500x g for 5 min and the supernatant was discarded. 15ml of sterile 
distilled water was added to resuspend the pellet by vortexing and the pellets was 
collected by centrifugation at 3500x g for 5 min. 10ml of ice-cold sterile distilled water 
was added and the process was repeated. For the final wash, 2ml of 1M sterile sorbitol 
was added and the process was repeated. 45µl of cells was aliquot into Eppendorf tubes 
for subsequent transformation and put on ice.    
2.4 Transformation of Yeast Cells 
3µl of plasmid DNA was added into 45µl of competent yeast cells and mixed well. 
The mixture was transferred into a 2mm electroporation cuvette (Biorad) and pulsed in 
Gene Pulser Xcell Electroporation Systems (BioRad). The setting for the pulse is set at 
1650mV, 5ms per pulse. The cells were then transferred and plated on YNB (-URA) 





2.5 Drop Assay 
To determine the phenotype of Hog1 mutants in both JBY13 and hog1Δpbs2Δ, yeast 
cells containing the mutant plasmids were inoculated into liquid YNB (-URA) medium 
and grown overnight at 30°C. The culture was then centrifuge at 3500x g and 
resuspended in fresh YNB (-URA) medium. A series of 10-fold dilutions which resulted 
in 5x100 to 5x104 cells in 5µl of culture with sterile distilled water in a 96-well plate. 5µl 
was dropped onto YNB (-URA) plates and YPD plates containing either 0.7M, 0.8M or 




2.6 Recombinant Protein Analysis 
2.6.1 Bacterial Strains and Growth Conditions 
Escherichia coli (E. coli) strains used in this study include TOP10 for DNA 
amplification and BL21 Rosetta for protein expression. Unless specified, TOP10 cells 
containing expression plasmids are maintained in Luria-Bertani (LB) medium containing 
ampicillin and BL21 Rosetta containing expression plasmids are maintained in LB 
medium containing ampicillin and chloramphenicol. Both strains are maintained at 37°C 
for growth. 
2.6.2 Site-Directed Mutagenesis of p38γ 
Site-directed mutagenesis was performed using the QuikChangeII Site-directed 
Mutagenesis kit (Agilent) according to the manufacturer’s instruction. The mutagenesis 
was performed on pBlueScriptIISK+ - human p38γ wild-type (WT) as a template with 
suitable primers. Primers are listed in Table 2. 
2.6.3 Subcloning of p38γ cDNAs into pHisParallel and pcDNA3 
Vectors 
Mutated p38γ in pBlueScriptIISK+ vectors were cloned into pHis-Parallel vector 
using the enzyme sites NcoI and NotI while it was cloned into pcDNA3 vector using the 
enzyme sites HindIII and NotI. Ligation was performed using T4 DNA Ligase (Thermo 






Table 2. Primers used in site-directed mutagenesis reactions for p38γ. 
p38γ R70S Forward 5’- GTCCGAGCTGTTCGCCAAGAGCGCCTACCGCGAGCTGCGC -3’ 
p38γ R70S Reverse 5’- GCGCAGCTCGCGGTAGGCGCTCTTGGCGAACAGCTCGGAC -3’ 
p38γ R70L Forward 5’- GTCCGAGCTGTTCGCCAAGCTCGCCTACCGCGAGCTGCGC -3’ 
p38γ R70L Reverse 5’- GCGCAGCTCGCGGTAGGCGAGCTTGGCGAACAGCTCGGAC -3’ 
p38γ R70K Forward 5’- GTCCGAGCTGTTCGCCAAGAAAGCCTACCGCGAGCTGCGC -3’ 
p38γ R70K Reverse 5’- GCGCAGCTCGCGGTAGGCTTTCTTGGCGAACAGCTCGGAC -3’ 
p38γ Y72H Forward 5’- CTGTTCGCCAAGCGCGCCCACCGCGAGCTGCGCCTGCTC -3’ 
p38γ Y72H Reverse 5’- GAGCAGGCGCAGCTCGCGGTGGGCGCGCTTGGCGAACAG -3’ 
p38γ T188A Forward 5’- GATGACTGGGTACGTGGTGGCCCGGTGGTACCGGGCTCCC -3’ 
p38γ T188A Reverse 5’- GGGAGCCCGGTACCACCGGGCCACCACGTACCCAGTCATC -3’ 
p38γ T188D Forward 5’- GATGACTGGGTACGTGGTGGACCGGTGGTACCGGGCTCCC -3’ 
p38γ T188D Reverse 5’- GGGAGCCCGGTACCACCGGTCCACCACGTACCCAGTCATC -3’ 
p38γ T188Q Forward 5’- GATGACTGGGTACGTGGTGCAGCGGTGGTACCGGGCTCCC -3’ 
p38γ T188Q Reverse 5’- GGGAGCCCGGTACCACCGCTGCACCACGTACCCAGTCATC -3’ 
p38γ Y326S Forward 5’- GAGCCCCAGGTCCAGAAGTCTGATGACTCCTTTGACGAC -3’ 
p38γ Y326S Reverse 5’- GTCGTCAAAGGAGTCATCAGACTTCTGGACCTGGGGCTC -3’ 
p38γ Y326A Forward 5’- GAGCCCCAGGTCCAGAAGGCTGATGACTCCTTTGACGAC -3’ 
p38γ Y326A Reverse 5’- GTCGTCAAAGGAGTCATCCGACTTCTGGACCTGGGGCTC -3’ 
p38γ Y326L Forward 5’- GAGCCCCAGGTCCAGAAGCTTGATGACTCCTTTGACGAC -3’ 
p38γ Y326L Reverse 5’- GTCGTCAAAGGAGTCATCAAGCTTCTGGACCTGGGGCTC -3’ 
p38γ Y326T Forward 5’- GAGCCCCAGGTCCAGAAGACTGATGACTCCTTTGACGAC -3’ 
p38γ Y326T Reverse 5’- GTCGTCAAAGGAGTCATCAGTCTTCTGGACCTGGGGCTC -3’ 
p38γ F330T Forward 5’- CAGAAGTATGATGACTCCACTGACGACGTTGACCGCACAC -3’ 
p38γ F330T Reverse 5’- GTGTGCGGTCAACGTCGTCAGTGGAGTCATCATACTTCTG -3’ 
p38γ F330R Forward 5’- CAGAAGTATGATGACTCCCGTGACGACGTTGACCGCACAC -3’ 
p38γ F330R Reverse 5’- GTGTGCGGTCAACGTCGTCACGGGAGTCATCATACTTCTG -3’ 
p38γ F330A Forward 5’- CAGAAGTATGATGACTCCGCTGACGACGTTGACCGCACAC -3’ 
p38γ F330A Reverse 5’- GTGTGCGGTCAACGTCGTCAGCGGAGTCATCATACTTCTG -3’ 
p38γ F330P Forward 5’- CAGAAGTATGATGACTCCCCTGACGACGTTGACCGCACAC -3’ 
p38γ F330P Reverse 5’- GTGTGCGGTCAACGTCGTCAGGGGAGTCATCATACTTCTG -3’ 
p38γ F330L Forward 5’- CAGAAGTATGATGACTCCCTTGACGACGTTGACCGCACAC -3’ 
p38γ F330L Reverse 5’- GTGTGCGGTCAACGTCGTCAAGGGAGTCATCATACTTCTG -3’ 
p38γ W340A 
Forward 
5’- GACCGCACACTGGATGAAGCGAAGCGTGTTACTTACAAAG -3’ 
p38γ W340A Reverse 5’- CTTTGTAAGTAACACGCTTCGCTTCATCCAGTGTGCGGTC -3’ 
p38γ W340R Forward 5’- GACCGCACACTGGATGAACGGAAGCGTGTTACTTACAAAG -3’ 
p38γ W340R Reverse 5’- CTTTGTAAGTAACACGCTTCCGTTCATCCAGTGTGCGGTC -3’ 
p38γ W340K 
Forward 
5’- GACCGCACACTGGATGAAAAGAAGCGTGTTACTTACAAAG -3’ 





2.6.4 Purification of Recombinant His-tagged p38γ Proteins 
BL21 Rosetta strain of E. coli cells containing the expression plasmid was grown 
overnight at 37°C in a starter culture containing 7.5ml of LB, ampicillin and 
chloramphenicol. This was diluted 1:40 to a final volume of 200ml of fresh LB 
containing both ampicillin and chloramphenicol. The culture was then grown at 37°C 
until it reaches an OD600 of 0.4-0.5. 0.3mM of IPTG was then added to the culture and 
allowed to grow at 30°C for 3 hours. The culture was centrifuged at 3200x g for 10 min 
and resuspended in 40ml of sonication buffer (50mM Tris-HCl, pH8.0, 10mM imidazole 
and 0.3M NaCl) and transferred into a 50mL tube and centrifuged at 4600x g for 15 min. 
The supernatant was then discarded, and the pellet was flash-frozen in liquid nitrogen and 
stored at -80°C.  
To lyse the cells, the pellet was thawed and resuspended in sonication buffer 
containing protease inhibitors (100µM phenylmethylsulfonyl fluoride (PMSF), 1µg/ml 
leupeptin, 1µg/ml pepstatin A, 1.9µg/ml aprotinin and 1mM benzamidine). Cell lysis was 
performed by sonication using the Sonic Dismembrator (Fisher Scientific) at amplitude 
30, for 10 seconds with 10 seconds interval for 6 repeats. The suspension was then 
centrifuged at 20000x g for 45 min to separate the cell lysate and cell debris.  
The supernatant was loaded into a column containing Ni-NTA agarose beads 
(Qiagen), pre-washed with sonication buffer.  After all the supernatant had flowed 
through the column, the beads are washed with 50ml wash buffer (50mM Tris-HCl, 
pH8.0, 30mM imidazole and 0.3M NaCl). Elution of the purified protein was done with 
2.5ml of elution buffer (50mM Tris-HCl, pH8.0, 250mM imidazole and 0.3M NaCl). The 
purified protein was then dialyzed overnight against a 2L solution of dialysis buffer 
(12.5mM HEPES, pH7.5, 100mM KCl, 0.5mM DTT and 6.25% glycerol). After an 
overnight dialysis, the purified protein was stored at -80°C in aliquots of 100µl. 
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2.6.5 Recombinant Protein Quantification 
Quantification of recombinant protein was done using the Bradford reagent (BioRad). 
Protein standard of bovine serum albumin (BSA) of 0.3µg, 0.6µg, 0.9µg 1.2µg were 
prepared. OD600 of standard and samples were measured using Infinite M200 Pro plate 
reader (Tecan) to quantify the protein concentration. All samples were done in duplicates. 
2.6.6 MKK6-Phosphorylation of p38γ 
Protein purification of a His-tagged double mutant MKK6EE, where the Ser-207 and 
Thr-211 had been mutated to Glu which rendered in an intrinsically active mutant was 
done as described above. 100µl of the purified MKK6EE was added to a tube containing 
1mg of purified 38γ. The mixture was added to a reaction buffer (50mM Tris-HCl, 
pH7.5, 0.1mM EGTA, 0.1% β-mercapethanol, 0.1mM sodium orthovanadate, 10mM 
MgAc) and a cocktail of Mg/ATP (500µM ATP, 75mM magnesium chloride (MgCl2), 
20mM MOPS, pH7.2, 25mM β-glycerophosphate, 5mM EGTA, 1mM sodium 
orthovanadate (Na3VO4), 1mM dithiothreitol (DTT)). The mixture was shaken at 30°C 
for 1 hour and the reaction was stopped by putting the mixture on ice. 
2.6.7 In vitro Kinase Assay 
All reactions with GST-ATF2, MBP or Elk1 as substrate were conducted in 96-wells 
plates in triplicates. To begin the reaction, 45µl of reaction mixture was added to 5µl of 
purified recombinant p38γ protein (final amount of 0.2µg). The final concentrations of 
the mixture is 25mM HEPES pH7.5, 20mM magnesium chloride (MgCl2), 20mM β-
glycerolphosphate, 0.1mM sodium orthovanadate (Na3VO4), 1mM dithiothreitol (DTT), 
40µg of substrate, 50µM of ATP and 0.5µCi of radioactive [γ-32P] ATP. The reaction was 
allowed to run for 10 min at 30°C with shaking and the reaction is stopped by quenching 
with 50µl of 0.5M EDTA pH=8.0 (final concentration of 250mM). After the reaction is 
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quenched, 15µl from each set of samples was subjected to SDS-PAGE and stained with 
Coomassie staining. The gel was then dried and exposed to film. 85ul from each well was 
dropped onto a 3x3 cm Whatman 3mm paper squares and air-dried. Each paper square 
was washed 3 times with 10% trichloroacetic acid (TCA) and 3% sodium pyrophosphate, 
10ml for each piece of paper square for 90 min each time with gentle shaking. After the 
3rd wash, the paper squares were washed overnight without shaking. The following day, 
the paper squares are washed twice with 100% ethanol for 20 min each time and allowed 
to air dry. The radioactivity of each square was counted using a scintillation counter 
running a 32P Cherenkov program. 
2.7 Cell Culture  
2.7.1 Cell Culture Maintenance 
Human embryonic kidney 293T (HEK293T) cells were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) (BioWest), supplemented with 10% fetal bovine 
serum (FBS) (BioWest) and 1% penicillin-streptomycin (BioWest). The cells were grown 
in T75 flasks (Nunc) in a humidified incubator at 37°C in 5% carbon dioxide (CO2).  
When passaging the HEK293T cells, cells were first washed with 10mL of phosphate 
saline buffer (PBS) before 1ml of 1% Trypsin-EDTA (BioWest) was added and cells 
were allowed to incubate at 37°C for 2-3 min before lightly tapping the T75 flask to 
dislodge any remaining attached cells. Cells were centrifuged in the Boeco C28-A 
centrifuge (Boeckel + Co.) at 100x g for 5 min. In order to determine cell viability, the 
cell was resuspended in DMEM and stained with Trypan Blue (Sigma-Aldrich) and 
counted using the haemocytometer (Neubauer).  
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2.7.2 Mycoplasma Detection 
HEK293T cells were checked for mycoplasma contamination using the Venor®GeM 
Classic kit (Minerva Biolabs) according to the manufacturer’s instruction.  
2.7.3 HEK293T Transfection 
HEK293T cells were transfected using the ScreenFect A kit (Wako) according to the 
manufacturer’s instructions. The cells were transfected with recombinant cDNA of 
human p38γ cloned into pcDNA3 vectors which contained a HA-tag. All plasmids, both 
wild-type and mutant, were identical except for the point mutations that were introduced.  
Additionally, cells were also co-transfected with either an empty pBabe vector or 
with a constitutively active, double mutant, variant of MKK6 (MKK6EE) cloned into 
pBabe vector. The MKK6EE cloned into pBabe vector also contained a HA-tag. 
2.7.4 Protein Extraction 
24 hours post-transfection, cells were washed with 1ml of PBS before adding 200µl 
of Laemmli’s buffer (40% glycerol, 12% SDS, 0.2M Tris-HCl, pH=6.8, 20% β-
mercapethanol, 0.25% bromophenol blue). Cells were then scraped using the cell scraper. 
The cells were boiled at 100°C for 10 min. The total protein concentration was then 
measured. 
2.7.5 Protein Quantification   
2µl of protein extracted was loaded onto a 1cm x1cm 3mm Chromatography Paper 
(Whatman) and air-dried. After drying, the paper were stained using a Coomassie 
solution (0.25% Coomassie G-250, 40% methanol, 10% acetic acid) for 30 min. The 
papers were then destained using a destaining solution (20% methanol, 7% acetic acid). 
Destaining was done until majority of the dye has been removed. The papers were dried 
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using a hotplate and transferred into a 24-well plate (Corning). 500µl of 3% SDS was 
added to each well and allowed to shake overnight. 200µl was transferred into a 96-well 
plate (Corning) and the OD600 was measured using Infinite M200 Pro plate reader 
(Tecan). The absorbance was measured against a standard using BSA. All samples were 
measured in duplicates. 
2.8 Western Blot 
2.8.1 SDS-PAGE Separation and Transfer of Protein to PVDF 
Membrane  
100ng for recombinant protein or 20µg of protein lysates were loaded into each well 
and separated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) using a 10% polyacramide gel at a constant current of 0.03A per gel in the Mini-
Protean Tetra System (BioRad). After separation, the proteins were transferred onto a 
PVDF membrane (BioRad) using the Trans-blot Turbo Transfer System (BioRad) at 18V, 
0.5A for 90 min.  
2.8.2 Detection and Analysis of Proteins with Antibodies 
PVDF membrane was blocked using 5% skimmed milk (Sigma) in 1x TBST (50mM 
Tris, 150mM NaCl, 0.1% TWEEN 20)  for 30 min at room temperature before being 
transferred into the primary antibody diluted 1:2000 in 5% BSA-TBST and left overnight 
at 4°C. After probing with primary antibody was complete (primary antibodies are listed 
in Table 4), the membrane was washed with 1x TBST 3 times for 10 min each. 
Subsequently, the membrane was transferred into the appropriate HRP-conjugated 
secondary antibody diluted 1:5000 in 5% skimmed milk-TBST and incubated for 60 min 




After wash, the proteins were visualized using the chemiluminescence detection 
reagent (Advansta). The chemiluminescence signal was developed on the x-ray medical 
film (FujiFilm). 
Table 3. List of primary antibodies used for Western Blot. 




1:2000 in 5% BSA Roche #11867423007 
Anti-p38γ 1:2000  in 5% BSA Cell Signalling #2307S 
Anti-p-p38 1:2000 in 5% BSA Cell Signalling #9211S 




3.1 Will any disruption of the “hydrophobic core” result in the self-
activation of Hog1? 
As described in the Introduction, 4 of the point mutations that rendered Hog1 
intrinsically active and independent of the MAPKK Pbs2 occurred in residues that 
interact with each to form a “hydrophobic core”. These residues are Tyr-68, Phe-318, 
Phe-322 and Trp-332 (Figure 3). We hypothesized that any modifications of these 
hydrophobic interactions would lead to intrinsically active variant of Hog1. This 
notion is conceptually important because it means that many conformations of the 
MAPK are capable of autoactivation and only a particular one (the native 
confirmation) prevents autoactivation. In order to address this, we introduced a 
variety of point mutations other than those already found to confer intrinsic activity 
to Hog1. As a control, we also introduced several other point mutations at Asp-170 
and Trp-320. Mutations at these residues were also found to confer intrinsic activity 
to Hog1 but they are not part of the hydrophobic core. The point mutation positions 
are as summarized in Table 4. We chose these particular mutations by replacing with 
a residue that was either (a) similar to the original residue (e.g. Tyr-68 to Phe-68), (b) 
similar to the residue which conferred intrinsic activity to Hog1 (e.g. His-68 to Lys-
68), (c) lacking the side chains of the original residue (e.g. Tyr-68 to Ala-68), (d) 
different in charge compared to the original residue (e.g. Phe-318 to Glu-318) or (e) a 




To test whether the mutations caused any unexpected loss-of-function effect, all 
mutant were introduced into hog1Δ cells and the ability of the transformants to grow 
under hyperosmotic stress was tested (Figure 5). To assess whether the mutants have 
acquired an intrinsic Pbs2-independent activity, they were introduced into hog1Δpbs2Δ 





Table 4. Point mutations which were reported to confer intrinsic activity to Hog1 
and the new point mutations inserted in this study. 
Position in Hog1 Mutants found to confer 
intrinsic activity to Hog1 
Mutations inserted in this 
study 













W320 W320Ra W320A 
W320F 
F322 F322La F322A 
F322W 








a Mutations which conferred intrinsic activity to Hog1 were described by Bell et al. 
(2001) 
b Mutations at the Phe-318 position were introduced into Hog1 by a colleague student in 





















Figure 4. A schematic presentation of the rationale for identifying intrinsically 
active, Pbs2-independent variants of Hog1. The upper row describes the wild type 
situation in which both the MAPKK Pbs2 and MAPK Hog1 are present and cells are able 
to grow normally under osmotic stress. The 2nd row indicates that growth under 
osmostress is dependent on Hog1. The 3rd row shows that growth under osmostress is 
Pbs2-dependent. The last row depicts the rationale that if a Hog1 mutant is able to rescue 
cells lacking both Pbs2 and Hog1 under stress, it is an intrinsically active, Pbs2-




3.1.1 Almost all residues that replaced Tyr-68, Phe-318, Phe-322 or 
Trp-332 conferred on Hog1 the ability to function 
independently of Pbs2  
All protein tested were able to rescue hog1Δ cells from osmotic stress showing that 
no mutations caused any significant defect to its catalytic activity except Hog1D170P 
(Figure 5A). To check which mutation rendered the protein intrinsically active (i.e. Pbs2-
independent), we introduced the mutated genes into hog1Δpbs2Δ cells and monitored 
their growth under osmotic stress (0.7M, 0.8M or 1.0M NaCl). Strikingly almost all 
newly generated mutants rescued hog1Δpbs2Δ cells, albeit to differing degrees (Figure 
5B).  
Residues introduced at Tyr-68 (Ala, Phe, Lys or Pro) rescued hog1Δpbs2Δ cells to 
different extent, including no rescue of the hog1Δpbs2Δ cells by Hog1Y68H (Figure 5B). 
However, when any residue was introduced at Phe-318 (Thr, Arg, Ala, Pro, Tyr, Glu or 
Val), all mutants were able to render Hog1 intrinsically active independent of Pbs2, 
although mutations to Tyr or Val resulted in a somewhat less efficient rescue of 
hog1Δpbs2Δ cells on 1M NaCl. Therefore, all mutants, except the native conformation of 
Phe-318, resulted in an intrinsically active, Pbs2-independent Hog1 (Figure 6). Mutants 
carrying mutations at Tyr-332 (replacing Tyr with Ala, Phe, Leu or Ser) were found to 
rescue hog1Δpbs2Δ cells efficiently. Additionally, when mutations were introduced into 
Phe-322 (Ala or Trp), both mutants resulted in partial rescue of hog1Δpbs2Δ cells (Figure 
5B). However, it was not as efficient as that seen in mutations at Tyr-68 or Phe-318. The 
fact that most of the mutants that we tested so far seem to have rendered Hog1 
independent of Pbs2 seems to indicate that the disruption of the “hydrophobic core” is 
sufficient enough to confer intrinsic activity to Hog1 and also suggests that the exact 
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conformation which allows autophosphorylation and subsequently activation of Hog1 is 
rather flexible to some extent. 
3.1.2 Mutations at Trp-320 and only specific mutations at Asp-170, 
both which are not involved in the αC-helix and L16 
hydrophobic interactions, also resulted in intrinsically active 
Hog1 
Mutations of Asp-170 or Trp-320 to Ala and Arg respectively resulted in intrinsically 
active Hog1 (Bell et al., 2001). Both Asp-170 and Trp-320 are not involved in the αC-
helix and L16-helix hydrophobic interactions but Asp-170 lies in the activation loop 
while Trp-320 lies in L16-helix.  We first tested point mutations at Asp-170 (into Gly, 
Phe, Pro or Ser). It was found that only certain residues resulted in the rescue of 
hog1Δpbs2Δ cells. In fact, only mutations into other small residues, Gly or Ser, allowed 
rescue of hog1Δpbs2Δ cells but not as well as Hog1D170A. However, Hog1D170F and 
Hog1D170P were not able to rescue hog1Δpbs2Δ cells at all (Figure 5B). Surprisingly, 
Hog1D170F which was able to rescue hog1Δ cells indicated that it was an intact protein 
which can be phosphorylated by Pbs2 but yet it was not able to rescue hog1Δpbs2Δ cells. 
Hog1D170P was able to rescue neither hog1Δ nor hog1Δpbs2Δ cells in response to osmotic 
stress.  Mutants carrying mutations at Trp-320 (Ala and Phe) were both able to rescue 
hog1Δpbs2Δ cells but Hog1W320A was barely rescuing hog1Δpbs2Δ cells. The results are 













Figure 5. Majority of the mutations introduced in residues which form the “hydrophobic core” conferred intrinsic activity to Hog1, 
independent of Pbs2, its upstream MAPKK in yeast cells resulting in rescue of hog1Δpbs2Δ cells on hyperosmotic media. A) Drop assay of 
a series of dilution of the mutants transformed into hog1Δ cells. Most are able to rescue hog1Δ under osmotic stress except Hog1D170P which was 
not able to rescue at all. B) Drop assay of a series of dilution of hog1Δpbs2Δ cells expressing the mutant Hog1 under osmotic stress. Only 














Figure 6. All mutants at Phe-318 are able to rescue hog1Δpbs2Δ cells under 
osmostress to varying degrees. Drop assay performed by colleague student Ms. Masha 
Tesker on mutations of Phe-318 in Hog1 on both hog1Δ and hog1Δpbs2Δcells on 1M 
NaCl plates. All mutants that replaced Phe-318 resulted in intrinsically active Hog1. 
 
Previous studies have shown that to bypass the requirements of Pbs2-dependent 
phosphorylation, intrinsically active Hog1 mutants gained the capability to undergo 
autophosphorylation (Maayan et al., 2012).  Since almost all Hog1 mutants we tested had 
acquired intrinsic, Pbs2-independent activity, resulting in the rescue of both hog1Δ and 
hog1Δpbs2Δ cells, this strongly suggests that the exact conformation of the “hydrophobic 
core” is not important for autophosphorylation. Rather any modification which affects the 
“hydrophobic core” results in the de-repression of autophosphorylation of Hog1.  
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3.2 Attempts to produce more intrinsically active variants of p38γ  
As described in “Introduction”, genetic screens identified mutations that rendered 
Hog1/p38α and Erks intrinsically active (Bell et al., 2001; Levin-Salomon et al., 2008) 
Sequence alignment of p38α, p38γ, Hog1 and Erk1/2 (Figure 7) showed several of the 
sites when mutated conferred intrinsic activity on Hog1/p38α or Erks, were also 
conserved in p38γ. We hypothesized that perhaps by mutating these residues in a similar 
manner that was done in Hog1/p38α and Erk2, we shall obtain intrinsically active p38γ as 
well. Particularly, since disrupting the “hydrophobic core” was sufficient to render Hog1 
intrinsically active, perhaps disrupting the “hydrophobic core” in p38γ would also render 
p38γ intrinsically active. Finally, in addition to the exact mutations that were relevant to 
Hog1/p38α and Erks, we also changed the relevant residues to other amino acid as well. 
Mutations are summarized in Table 5. All point mutations that were performed were 
unique and have not been reported in any previous publication. 
 Additionally, a mutation at Thr-188 was also included. This position in Erk2 
(also Thr-188), when mutated to aspartic acid (to simulate Thr-188 phosphorylation), 
resulted in pathological cardiac hypertrophy in a mouse model (Lorenz, Schmitt, Vidal, 
& Lohse, 2009). Since p38γ is found to be highly expressed in cardiac muscles and Thr-
188 was found to be conserved in both p38γ and Erk2, it would be interesting to observe 




























Figure 7. Sequence alignment of Hog1/p38α and Erk1/2 shows that residues that 
when mutated rendered Hog1/p38α or Erk1/2 intrinsically active are highly 
conserved.  Numbering of residues was based on p38γ positions. Several emphasis that 
are found in the alignment:  (i) TXY motif unique to MAPKs is highlighted in red (ii) 
Position where mutations which were previously introduced into p38γ is marked by * (iii) 
Residues which conferred intrinsic activity to some MAPKs and are highly conserved 
between the 5 MAPKs are label in a box (iv) Residues which conferred intrinsic activity 





Table 5. Point mutations which rendered Hog1, Erk1/2 and/or p38α intrinsically 
active (MAPKK-independent) and equivalent position in p38γ and mutations 
produced for each conserved site. 




  R70 R70S 
R70L 
R70K 
 Y68Hb Y69He,f Y72 Y72H 
T188D 
(Erk2)*,c 



















 W332Rb W337Re,f W340 W340A 
W340R 
W340K 
Point mutations which conferred intrinsic activity are indicated with bold letters 
a Mutations in Erk1/2 were described by Levin-Salomon et al. (2008) 
b Mutations in Hog1 were described by Bell et al. (2001) 
C Mutations in Erk1/2 in mouse model were described by Lorenz et al. (2008) 
d Mutations in p38α were described in Avitzour et al. (2007) 
e Mutations in p38α were described by Diskin et al. (2004) 
f Mutations in p38α were described by Askari et al. (2007)  
* This residue did not confer intrinsic activity to Erk2 in vitro but was reported to be 





3.3 In vitro characterization of purified recombinant protein 
3.3.1 None of the mutants of p38γ were spontaneously 
phosphorylated when assayed as purified recombinant 
proteins 
Intrinsically active variants identified so far were spontaneously phosphorylated at 
their TGY motif when purified from Escherichia coli (E .coli) cells (Avitzour et al., 
2007; Diskin et al., 2004). To assess whether recombinant p38γ mutants were 
spontaneously phosphorylated when purified from bacteria, a Western Blot was 
performed using anti-phospho-p38 antibodies. As a positive control, we used the 
intrinsically active variant of p38α, p38αD176A+F327S. None of the p38γ mutants reacted 
with the anti-phospho-p38 antibody (Figure 8). Notably, even though the p38γ mutants 
were not found to be spontaneously phosphorylated, it is not indicative that they are not 
intrinsically active as p38γD179A which is the only active variant found so far was not 
found to be phosphorylated either. 
We further tested whether the mutants are capable of any autophosphorylation 
activity in vitro. All mutant p38γ were incubated with a kinase buffer containing ATP 
without MKK6EE and a Western Blot analysis was performed. Unfortunately none of the 
mutants except the positive control showed detectable phosphorylation (Figure 9, upper 
panel). To test whether the mutants might have lost their ability to be phosphorylated on 
the Thr and Tyr residue of the TXY motif, MKK6EE (the intrinsically active variant of 
MKK6) was added in a parallel set of control experiments. All mutants were strongly 
phosphorylated upon addition of MKK6EE as concluded from their strong reaction with 
anti-phospho-p38 antibodies. Thus, none of the mutants lost the ability to be 














Figure 8. All recombinant proteins of p38γ mutants tested were not spontaneously 
phosphorylated when purified from E. coli.  Western Blot analysis was performed with 
the antibodies indicated, on purified proteins from E. coli. Recombinant proteins which 
were maintained in dialysis buffer overnight after purification were immediately added to 
an equal amount of 2x Laemmli’s Buffer and boiled at 100°C for 10 minutes and 30µg of 



















Figure 9. None of the p38γ mutants autophosphorylate in vitro in the absence of MKK6EE but all mutants can be phosphorylated by its 
upstream MAPKK. Western Blot analysis with the relevant antibodies shows that all except p38αD176A+F327S did not undergo autophosphorylation 




3.3.2 All mutants tested did not show any activity in in vitro kinase 
assay 
Western Blot of purified p38γ mutant recombinant protein seemed to indicate that 
p38γ does not undergo autophosphorylation. However, it could be that the 
autophosphorylation was very weak and was not detectable by Western Blot. To 
determine whether the p38γ mutants gained any basal activity, we tested them in vitro 
using radioactive ATP and GST-ATF2 as the substrates and p38αD176A+F327S as a positive 
control. None of the 10 mutants that were tested showed any intrinsic activity in vitro as 
GST-ATF2 was not phosphorylated (Figure 10). To ensure that the p38γ mutants that the 
lack of phosphorylation of its substrate ATF2 was not due to the loss of catalytic activity 
per se, we repeated the same experiment but included an activation step in which p38γ 
mutants were incubated with ATP and MKK6EE. All mutants and controls were active 
showing that the protein did not lose its catalytic activity. This indicated all p38γ mutants 
tested were not catalytic dead and were MKK-dependent for the phosphorylation of 








Figure 10. None of the p38γ mutants tested showed any intrinsic activity. In vitro 
kinase assay was performed with the indicated purified p38γ proteins with incubation 
with GST-ATF2 in a kinase assay mixture containing [γ-32P] ATP.  Reaction was stopped 
and samples were loaded onto SDS-PAGE. Coomassie Brilliant Blue staining verified the 




3.3.3 MBP is a better substrate than ATF2 for monitoring p38γ 
activity in vitro 
A valid explanation for the lack of intrinsic activity could be that GST-ATF2 is a low 
affinity substrate for p38γ so that low levels of activity would not be monitored. 
Therefore, we decided to test 2 other substrates, myelin basic protein (MBP) and Elk-1 
which were known to be phosphorylated by all families of MAPKs unlike ATF2 which 
was more specific to p38s and Jnks. Both MBP and Elk-1 were not used initially as they 
were not as specific to p38s as ATF2. 
Elk-1 is a transcription factor which can be phosphorylated by Erks, Jnks, and p38s 
but is primarily phosphorylated by Erk1/2 and has at least 9 residues in the C-terminal 
domain able to be phosphorylated by MAPKs (Besnard, Galan-Rodriguez, Vanhoutte, & 
Caboche, 2011; Cruzalegui, Cano, & Treisman, 1999) while MBP is a commonly used 
substrate that can be phosphorylated by many kinases, including PKA, PKC cyclin-
dependent and calmodulin-dependent protein kinases and also MAPKs. MBP has at least 
2 sites (Thr-94 and Thr-97) which are phosphorylated in vivo by MAPKs (Boggs, 
Rangaraj, Gao, & Heng, 2006). Since both Elk-1 and MBP can be phosphorylated at 
multiple sites by MAPKs, we hope that the substrate affinity of Elk-1 and MBP to p38γ 
can be higher than that observed in GST-ATF2. 
We incubated ATF2, MBP and Elk-1 with p38γWT and p38γD179A with and without 












Figure 11. MBP has the highest change in counts per minute (CPM) between p38γWT and p38γD179A.  A) Kinase assay using 
radioactive 32P was used to quantify the amount of phosphorylated substrate. MBP showed the most significant increase in 
phosphorylation as compared to the 2 other substrates, ATF2 and ELK1. Subsequent kinase assay using radioactive 32P use MBP 
as the substrate. B) Kinase assay using MBP as the substrate showing the marginal increase in p38γ activity in p38γD179A and 
comparable activity of the p38γWT and p38γD179A when activated by MKK6EE. 
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3.4 Testing p38γ Mutants in HEK293T cells 
3.4.1 All of the p38γ mutant were spontaneously phosphorylated 
when transiently expressed in HEK293T cells 
All p38γ mutants produced were introduced into cells of the human cell line 
HEK293T. Since we were interested whether the transiently expressed p38γ proteins 
were intrinsically active, HEK293T cells were used as a simple and powerful tool that 
allowed high transfection efficiency and would allow us to study the phosphorylation 
status of p38γ in vivo easily. Forty eight hours post transfection protein lysates were 
prepared and probed with anti-phospho-p38. The premise was that p38γWT would not be 
phosphorylated at all in quiescent cells so that any mutants that gained some spontaneous 
phosphorylation would be readily observed. Unexpectedly, all p38γ molecules including 
p38γWT were spontaneously phosphorylated when expressed in HEK293T cells (Figure 
12). We currently cannot explain this observation. Perhaps relevant signal exists in the 
























Figure 12. All p38γ mutants including p38γWT were spontaneously phosphorylated 
even in the absence of MKK6EE. Cell were harvested and lysed with Laemmli sample 
buffer and boiled. 20µg of each sample was loaded in each well and probed with relevant 
antibodies.   
3.4.2 Testing for the Presence of Mycoplasma in HEK293T Cells 
To confirm whether there could be a chance that mycoplasma could have 
contaminated the HEK293T cells resulting in spontaneous phosphorylation of p38γ, we 







Figure 13. Presence of mycoplasma contamination in the HEK293T cell culture. 
Using the negative and positive controls provided by the kit, the PCR results indicates 





In its first part, this study focused on a novel structural element that was discovered 
via intrinsically active mutants of the yeast MAPK Hog1 and the mammalian MAPK 
p38α. This element, the “hydrophobic core”, was discovered by the fact that several 
different activating mutations, which were selected in a way that was unbiased towards 
protein domains, occurred in residues that form it. 
In this study, we have shown that this motif seems to act as a suppressor of 
autophosphorylation and by disrupting the core, Hog1 is rendered intrinsically active. By 
introducing a panel of different point mutations to these residues other than those 
previously shown to confer intrinsic activity found, we verified this hypothesis. From 
this, we have shown that it is not the mutations that were identified from the unbiased 
screen which per se rendered Hog1 active but rather any mutations which alters the 
hydrophobic core renders the mutant Hog1 to undergo autophosphorylation and become 
intrinsically active. It seems that disruption of this hydrophobic interaction supports 
autophosphorylation of Hog1 and that the actual active conformation is not very strict 
and allows some flexibility. The structure-function implications of the finding are 
somewhat striking. The finding suggests that no particular conformation supports auto-
activation. Rather, any modifications disrupting the “hydrophobic core” impair its ability 
to act as a suppressor of autophosphorylation.        
The hydrophobic core regions of ERKs and JNKs seem to be fundamentally different 
from those of Hog1 and p38. Insertion of point mutations equivalent to the residues 
which rendered Hog1/p38 did not affect activity of the ERK sub-family. Mutations which 
did confer intrinsic activity to Erk molecules did not lie in hydrophobic core (M. A. 
Emrick, Hoofnagle, Miller, Ten Eyck, & Ahn, 2001; Michelle A. Emrick et al., 2006; 
Levin-Salomon et al., 2008). Equivalent mutations were also introduced into JNK2 but it 
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did not affect JNK2 (our unpublished results). In addition, there have been no active 
variant of JNK isoform reported. Therefore this suggests that the function of the 
“hydrophobic core” as a suppressor of autophosphorylation may be specific to Hog1 and 
p38. 
Significant differences between the hydrophobic cores of p38 and Hog1 may explain 
why the core of Hog1 is more permissive for activation. Namely, in p38α, in addition to 
the hydrophobic interaction, there is an additional salt bridge between Glu-328 and Arg-
70. It was also reported that p38γ has a Asp-331 replacing Glu-328 in p38α which does 
not form the salt bridge (Diskin et al., 2007). This meant that maybe p38γ was more 
similar to Hog1 due to the absence of the salt bridge as in p38α and the disruption of the 
“hydrophobic core” could also be sufficient to render p38γ intrinsically active.  
One issue that has not been addressed in the thesis is the expression levels of Hog1 
and the biochemical aspect in each of the mutants produced. We have only tested the 
mutants biologically, namely the ability to rescue hog1Δpbs2Δ cells under osmostress. 
We have not yet identify why certain mutants (ie. Hog1Y68H, Hog1D170F, Hog1D170P) were 
unable to rescue hog1Δpbs2Δ cells under osmostress. Further investigation into this 
phenomenon can be done by performing Western Blots on all Hog1 mutants and monitor 
their phosphorylation status. It is possible that some of the mutants are less well 




The second part of the thesis focuses on production of intrinsically active variant of 
p38γ. So far, only one intrinsically active variant of p38γ, p38γD179A has been reported 
and it has very low activity levels (6% of dually phosphorylated p38γWT). By 
incorporating the knowledge from the first part of the thesis, we tried to insert the 
equivalent mutations and other point mutations in the “hydrophobic core” which rendered 
Hog1/p38α intrinsically active into p38γ and monitor their activity. 
Currently, there are no efficient inhibitors of p38γ available and the only intrinsically 
active variant of p38γ has very low activity. By trying to produce a more intrinsically 
active variant of p38γ by introducing the point mutations, this could allow the 
development of inhibitor of p38γ through the use of high throughput system for drug 
screening. It could also be possible to use the p38γ mutants in a yeast expression system 
for drug screening to discover novel inhibitors, such as JX401, an inhibitor of p38α 
which was discovered through such a screen (Friedmann et al., 2006). 
However, none of the p38γ recombinant proteins including p38γD179A showed any 
spontaneous phosphorylation in vitro. Even after addition of the ATP in the kinase buffer 
added, none of the recombinant proteins showed autophosphorylation. To ensure that the 
p38γ recombinant protein did not lose its ability to be phosphorylated on the 
phosphoacceptors, Thr-183 and Tyr-185, MKK6EE was added together with the kinase 
buffer. All mutants showed that they were able to be phosphorylated on their 
phosphoacceptors and are catalytically active. This seems to disprove the assumptions 
that since p38γ is rather similar to Hog1 as it lacks a salt bridge in the “hydrophobic 
core” unlike p38α, it could be easily rendered active similar to Hog1. Disruption of the 
hydrophobic core which is sufficient to render Hog1 intrinsically active is insufficient to 
render p38γ active independent of MKK6. This preliminary result highlighted that even 
though p38α is about 61% identical to p38γ, mutations at the conserved positions which 
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conferred intrinsic activity to Hog1/p38α failed to confer any intrinsic activity to p38γ. 
This seems to indicate that the regulatory element of p38γ could be different from that of 
Hog1/p38α in addition to the “hydrophobic core” identified. 
One of the most common ways of activating a particular kinase can be achieved by 
the phosphorylation of a particular Thr residue in their activation loop. Undergoing 
autophosphorylation to activate itself is performed by many kinases (Huse & Kuriyan, 
2002; Lochhead, 2009). MAPKs bring the regulation of its activation a level higher by 
requiring a dual-phosphorylation on both a Thr and a neighbouring Tyr residue (Kyriakis 
& Avruch, 2012). 
It has previously been reported that Hog1 is still able to undergo autophosphorylation 
and subsequently activation, even with the requirement of the dual-phosphorylation. It 
loses this autophosphorylation capability when a 7 amino acids long sequence (Y337-
F343) is deleted. Similarly, p38αD179A+F327S, the intrinsically active variant of p38α used in 
this thesis also requires these conserved residues (Y342-F348) for its intrinsic activity. 
The loss of this region abolished autophosphorylation capabilities (Maayan et al., 2012). 
These 7 amino acids long sequence is also conserved in p38γ (Y354-F360). Yet, even 
with this region present in p38γ as well as insertion of point mutations into residues 
which conferred intrinsic activity to Hog1/p38α failed to produce intrinsic activity to any 
of the 20 p38γ mutants produced in this thesis work. This seems to indicate that maybe in 
addition to the pre-requisite of these 7 amino acids region, there is additional layer of 





It was also shown that the long C-terminal tail which is present in Hog1 is 
responsible for suppression of autophosphorylation (Maayan et al., 2012). This long C-
terminal tail (which makes Hog1 80 amino acid longer than p38α) does not exist in p38. 
The removal of this long C-terminal tail resulted in Hog1 becoming intrinsically active. 
This tail is absent in both p38α and p38γ but yet with the absence of the tail which is 
responsible for suppression of autophosphorylation in Hog1 and the point mutations at 
site which conferred intrinsic activity to Hog1/p38α, no intrinsically active variant of 
p38γ was found indicating maybe some other structural element could be responsible for 
this suppression of autophosphorylation in p38γ. 
In this Master’s thesis, we have created a library of 20 mutants of p38γ. However, in 
vitro, none of the mutants seem to be more intrinsically active than the previously found 
p38γD179A. It was to be noted that only a qualitative analysis of the kinase assay 
(radiogram) was performed. A quantitative analysis of the kinase assay (using a 
scintillation counter) would be able to provide a numerical comparison of the activity 
levels of the mutants relative to that of the dually-phosphorylated p38γWT. The other 10 
mutants which have yet to be tested with the kinase assay should also be completed to 
confirm whether they are intrinsically active. 
In addition to the 20 mutants produced in this thesis, p38γD179A was the only 
intrinsically active p38γ variant found so far. However, this was also the only point 
mutation done at this particular position. Several other mutations at position Asp-179 of 
p38γ have already been designed and constructed. These mutants can be transferred into 
both the pHis-parallel vector (for in vitro studies) and pcDNA3 vector (for transfection to 
mammalian cells) and perform the same experiment as previously described. It might 
also be worthwhile to test the entire array of 20 amino acids to try to elucidate the 
mechanism in which p38γ gains intrinsic activity through the mutation at position 179. 
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One possible reason why there was no intrinsically active p38γ discovered, could 
simply be that GST-ATF2 is not the optimal substrate. The activity of the mutants could 
have been too low to be detected due to the low affinity of ATF2 to p38γ. It might be 
worthwhile to test all mutants again on substrates such as Elk1 and especially MBP, 
based on the results shown in Figure 11. This could help in identifying low activity singe 
mutants for generating further compound mutants. 
Surprisingly, all p38γ were found to be spontaneously phosphorylated when 
overexpressed in HEK293T cells. p38β was reported to show spontaneous 
phosphorylation in vitro but not in vivo, indicating that there is something inherent in 
mammalian cells that suppress autophosphorylation in vivo  (Beenstock et al., 2014). 
However, in p38γ, rather than having something inherent to suppress 
autophosphorylation, something else is causing the autophosphorylation of p38γ in vivo. 
This is surprising as unlike the in vitro study when none of the p38γ mutants were found 
to be spontaneously active, all of the p38γ tested were spontaneously phosphorylated 
which is the opposite of the result seen for p38β (Beenstock et al., 2014) and is 
something that we cannot explain at the moment.  
One possible reason that could have led to the spontaneous phosphorylation could be 
due to the presence of mycoplasma contamination. To test whether there is a possibility 
that there is mycoplasma contamination, we used the Venor®GeM Classic kit and found 
that there is indeed the presence of mycoplasma in the HEK293T cell culture. However, 
it is not likely that the mycoplasma contamination would have resulted in the strong 
spontaneous phosphorylation that was observed with all p38γ mutants including the wild-
type as well. When p38αWT was used to transfect the same batch of HEK293T cell 
culture, there was no visible spontaneous phosphorylation was observed (summarized in 
Supplementary Fig 1.) However, the experiment should be repeated on afresh, non-
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mycoplasma contaminated HEK293T cells to confirm that the spontaneous 
phosphorylation was not due to the mycoplasma contamination.  
A review of p38γ literature revealed that many in vivo studies of p38γ have been 
conducted in different tissue culture in cell lines including primary human fibroblast, 
mouse embryonic fibroblast (MEF), NIH 3T3, C2C12 and L8 cells (Kwong et al., 2009; 
Lechner et al., 1996; Sabio et al., 2010). However, very little work has been described for 
the expression level or phosphorylation state of p38γ in transiently transfected HEK293T 
cells. For example, Lechner et al. (1996) describe the overexpression of p38γ in 
HEK293T cells but did not show the phosphorylation state of p38γ. The lack of any 
reports seems to indicate that maybe, HEK293T cells are not suitable for checking the 
expression and phosphorylation states of p38γ as all p38γ have been found in this thesis 
to be spontaneously activated. 
Further in vivo analysis of the library of p38γ could also be performed. Currently, 
these mutants were only expressed in HEK293T cells which do not properly simulate 
physiological conditions where p38γ is highly expressed. It would be interesting to 
observe the effects of mutant p38γ in cell lines such as the L8, a myogenic cell line from 
primary rat skeletal muscle cell culture or C2C12 which is also a myogenic cell line but 
from mouse. These 2 cell lines have more similar physiological conditions since p38γ is 
highly expressed in muscle cells. In addition to cell culture work, it would also be useful 




In conclusion, this Master’s thesis has established 2 points. Firstly, almost all point 
mutations in residues residing in the “hydrophobic core” rendered Hog1 intrinsically 
active. This finding has important structure-function implications. Normally, MAPKs are 
not able to undergo spontaneous phosphorylation and require MAPKKs for their 
activation. This “hydrophobic core” seems to act as a critical motif to prevent 
autophosphorylation. Mutations at these residues that form the core in ERKs and JNKs 
did not confer any intrinsic activity indicating that there are other structural elements 
preventing autophosphorylation. In Hog1, any mutations resulted in intrinsically active 
Hog1 even though the residues that form the core are highly conserved in all MAPKs. 
However, only specific mutations to certain residues rendered p38α intrinsically active. It 
seems that the cell has developed other structural elements that could further strengthen 
the repression of intrinsic activity of mammalian MAPKs.  
Secondly, point mutations which have conferred Erk1/2 and Hog1/p38α intrinsically 
active were not able to confer intrinsic activity to p38γ at least in vitro. The lack of any 
positive intrinsically active variant of p38γ from the project and the absence of reports of 
any new intrinsically active variants of p38γ in literature seems to indicate that it could be 
difficult to produce a more intrinsically active variant of p38γ than p38γD179A. Despite 
p38α and p38γ sharing 61% identity, the regulatory mechanism for autophosphorylation 
between this two isoforms seems to be different as mutations which confer intrinsic 
activity to p38α does not provide this gain-of-function to p38γ. This seems to also 
indicate that there could be some differences in the regulation of p38γ as that from other 
MAPKs. However the issue is less clear in cell culture. as, all p38γ including p38γWT 
were spontaneously phosphorylated indicating maybe something in the cell which is 
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Supplementary Figure 1. All p38γ wild-type and mutant underwent spontaneously 
phosphorylation but not p38αWT in transiently transfected HEK293T cells. Cells 
were harvested and lysed with Laemmli sample buffer and boiled. 10µg of each sample 
was loaded in each well except for p38αWT where 20µg of sample was loaded and probed 
with relevant antibodies.   
